3/3/2006

France's largest biotech company, NicOx, signed a multimillion-dollar deal with Pfizer giving the American company exclusive rights to its technology for developing treatments for eye diseases. The technology is based on nitric oxide-donating techniques for use in opthalmology.

Full Story:
MSNBC

Related Summaries